Musculoskeletal Collaboration and Licensing Deals 2016-2026

Description

The definitive benchmark for musculoskeletal dealmaking

Musculoskeletal partnering spans a range of degenerative, inflammatory, and injury-related conditions, with deal structures reflecting diverse treatment approaches across pharmaceuticals, biologics, and orthopedic interventions.

This report provides a comprehensive and structured analysis of 509 musculoskeletal collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how musculoskeletal deals are structured in practice, allowing you to:

Benchmark comparable transactions with confidence
Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
Define realistic market parameters
Clear insight into how deal terms vary by stage, asset type, and partner profile
Support valuation and structuring decisions with evidence
Ground internal discussions in real transaction data rather than assumptions
Understand how leading companies approach dealmaking
Visibility into partner behaviour and recurring deal structures across a clinically diverse and treatment-focused landscape
Full visibility into deal structure and execution
Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

Rights granted and retained
Development and commercialization responsibilities
Financial structures and payment triggers
Key contractual provisions and protections
This level of transparency is critical to understanding how value, risk, and control are allocated within musculoskeletal partnerships, particularly across chronic conditions and intervention-driven treatment approaches.
Designed for real-world BD and strategy use

The report is widely used to:

Structure and benchmark live transactions
Prepare for negotiations with well-defined market context
Evaluate partnership opportunities and counterparties
Support internal strategy with robust, defensible data
What's included
509 musculoskeletal collaboration and licensing deals
Financial terms, including upfronts, milestones, and royalties where disclosed
Fully searchable deal directory (by company, therapy, and technology)
Direct access to SEC-filed agreements and source documents
Analysis of deal trends, key transactions, and active dealmakers
A trusted, evidence-based reference for musculoskeletal dealmaking
Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how musculoskeletal partnerships are structured, negotiated, and valued.

Product Code: CP2215

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in musculoskeletal dealmaking

2.1. Introduction
2.2. Musculoskeletal partnering over the years
2.3. Musculoskeletal partnering by deal type
2.4. Musculoskeletal partnering by industry sector
2.5. Musculoskeletal partnering by stage of development
2.6. Musculoskeletal partnering by technology type
2.7. Musculoskeletal partnering by therapeutic indication

Chapter 3 - Financial deal terms for musculoskeletal partnering

3.1. Introduction
3.2. Disclosed financials terms for musculoskeletal partnering
3.3. Musculoskeletal partnering headline values
3.4. Musculoskeletal deal upfront payments
3.5. Musculoskeletal deal milestone payments
3.6. Musculoskeletal royalty rates

Chapter 4 - Leading musculoskeletal deals and dealmakers

4.1. Introduction
4.2. Most active in musculoskeletal partnering
4.3. List of most active dealmakers in musculoskeletal
4.4. Top musculoskeletal deals by value

Chapter 5 - Musculoskeletal contract document directory

5.1. Introduction
5.2. Musculoskeletal partnering deals where contract document available

Chapter 6 - Musculoskeletal dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by musculoskeletal therapeutic target
Deal directory
Deal directory - Musculoskeletal deals by company A-Z
Deal directory - Musculoskeletal deals by technology type
Deal type definitions
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Musculoskeletal partnering since 2016
Figure 2: Musculoskeletal partnering by deal type since 2016
Figure 3: Musculoskeletal partnering by industry sector since 2016
Figure 4: Musculoskeletal partnering by stage of development since 2016
Figure 5: Musculoskeletal partnering by technology type since 2016
Figure 6: Musculoskeletal partnering by indication since 2016
Figure 7: Musculoskeletal deals with a headline value
Figure 8: Musculoskeletal deals with upfront payment values
Figure 9: Musculoskeletal deals with milestone payment
Figure 10: Musculoskeletal deals with royalty rates
Figure 11: Active musculoskeletal dealmaking activity since 2016
Figure 12: Top musculoskeletal deals by value since 2016